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Abstract
Interventions to address micronutrient deficiencies have large potential to reduce the related disease and economic
burden. However, the potential risks of excessive micronutrient intakes are often not well determined. During the
Global Summit on Food Fortification, 9–11 September 2015, in Arusha, a symposium was organized on micronutri-
ent risk–benefit assessments. Using case studies on folic acid, iodine and vitamin A, the presenters discussed how to
maximize the benefits and minimize the risks of intervention programs to address micronutrient malnutrition.
Pre-implementation assessment of dietary intake, and/or biomarkers of micronutrient exposure, status andmorbid-
ity/mortality is critical in identifying the population segments at risk of inadequate and excessive intake. Dietary
intake models allow to predict the effect of micronutrient interventions and their combinations, e.g. fortified food
and supplements, on the proportion of the population with intakes below adequate and above safe thresholds.
Continuous monitoring of micronutrient intake and biomarkers is critical to identify whether the target population
is actually reached, whether subgroups receive excessive amounts, and inform program adjustments. However, the
relation between regular high intake and adverse health consequences is neither well understood for many
micronutrients, nor do biomarkers exist that can detect them. More accurate and reliable biomarkers predictive
of micronutrient exposure, status and function are needed to ensure effective and safe intake ranges for vulnerable
population groups such as young children and pregnant women. Modelling tools that integrate information on
program coverage, dietary intake distribution and biomarkers will further enable program makers to design
effective, efficient and safe programs.
Keywords: micronutrient malnutrition, public health, nutritional interventions, food fortification, nutritional
supplements, risk–benefit assessment.
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Introduction
More than 2 billion people globally are estimated to
suffer from micronutrient deficiencies (von Grebmer
et al. 2014). Iron, zinc, vitamin A, iodine, folate and
other vitamin B deficiencies are among the most wide-
spread global micronutrient deficiencies (Muthayya
et al. 2013). Factors that contribute to poor micronutri-
ent intake and absorption include poor dietary
diversity, poor nutrient density of staple-based comple-
mentary foods, anti-nutritional factors in plant-based
foods and environmental enteropathy. Metabolic
requirements for micronutrient are especially high
during early development, pregnancy and lactation.
Disease conditions resulting from infections can further
aggravate micronutrient deficiencies (Katona &
Katona-Apte 2008).
Strategies such as targeted supplementation with
vitamin A, or universal salt iodization, oil fortification
with vitamin A, or flour fortification with iron or folic
acid, are often part of national strategies to address
the problem of micronutrient malnutrition among
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vulnerable groups throughout the life cycle. Overcom-
ing deficiencies of micronutrients can have a potential
benefit in terms of young child survival, growth and
development and preventing intrauterine growth
restriction and low birth weight (Black et al. 2013). Re-
views such as the Copenhagen Consensus have consis-
tently ranked micronutrients as the most cost-effective
development intervention (Copenhagen Consensus
Panel 2012). Economic analyses suggest that fortifica-
tion and/or targeted supplementation with, for in-
stance, iron, zinc, vitamin A, folic acid and iodine can
be highly cost-effective (Horton 2006; Horton et al.
2008; Edejer et al. 2005; Yi et al. 2011). Fortification will
not reach all individuals but can be a cost-effective
strategy provided that a centrally processed, affordable
fortified food vehicle is available and either the defi-
ciency is widespread or only a small group is affected
but the adverse effects because of the deficiency are
very costly (Horton 2006). Targeted micronutrient
programs such as home fortification or periodic high-
dose supplements have the advantage to deliver
micronutrients of concern to the vulnerable subpopula-
tion(s) without unnecessarily exposing other groups in
the population. In order for supplementation to be
cost-effective, the defined target group should be read-
ily reached with little compliance issues (Horton 2006).
When implementingmicronutrient programs there is
the risk of providing insufficient or excessive amounts,
missing those at risk or redundant coverage (coverage
of individuals with adequate intake, or coverage by
more programs than necessary), potentially resulting
in inadequate or excessive intakes and poor
cost-effectiveness. Designing an effective and safe forti-
fication or supplementation program imposes the dual
challenge of reaching the target population groups at
most risk of micronutrient deficiency while avoiding
overexposure of individuals at the high end of the
intake distribution curves (European Food Safety
Authority (EFSA) 2010). This may pose particular
challenges regarding micronutrient interventions that
exert benefits in the target population but unintention-
ally adverse effects in a subgroup of this target popula-
tion with already high intake or status of the
micronutrient (e.g. ‘targeted’ vitamin A supplementa-
tion) (European Food Safety Authority (EFSA)
2010). Increasingmicronutrient intakes through univer-
sal fortification can deliver potential benefits to defi-
cient population groups, but sometimes also risks in
other population groups when consumed in excess
(e.g. folic acid fortification to prevent neural tube
defects in the unborn child versus masking of vitamin
B12 deficiency in elderly) (European Food Safety
Authority (EFSA) 2010).
Values have been set for the intake of each micronu-
trient below which the risk for adverse health effects is
likely to increase. The risk of an inadequate intake
increases as an individual’s intake falls further below
the recommended intake (Food and Nutrition Board
& Institute of Medicine (IOM) 2000). At two standard
deviations below the recommended intake, i.e. the
estimated average requirement (EAR), the risk is
approximately 50% that an individual’s requirements
are not met. Adverse health consequences because of
a micronutrient deficiency condition increase in
Key messages
• Monitoring of data (dietary intake, program coverage, biomarkers and morbidity) among vulnerable population
groups is essential to optimize effectiveness, safety, and efficiency of micronutrient programs.
• Modelling tools are needed that predict the effectiveness, safety, and efficiency ofmicronutrient programs by integrat-
ing above data.
• Research is needed to identify biomarkers predictive of micronutrient exposure, status, and potential health conse-
quences of inadequate and especially excessive micronutrient exposure. This may help setting the appropriate no-ob-
served-adverse-effect or lowest-adverse-effect level, currently often based on scant data, particularly for young
children.
• More insight is needed into the antagonistic effects resulting from complex interactions between micronutrients,
drugs, and infections.
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incidence and/or severity the further the usual intake
falls below the EAR (Renwick et al. 2004). Therefore,
reducing the number of individuals with inadequate
micronutrient intakes can be expected to have clear
benefits on micronutrient deficiency-related morbidity
especially when the morbidity is severe and/or chronic.
However, the adverse health consequences of defi-
ciency are far better understood than the evidence base
related to the consequences of excess, if any. The
‘excess’ level of intake is neither well understood and
defined for many micronutrients, nor do biomarkers
exist that can detect early adverse effects. Considerable
uncertainty exists for many micronutrients about
the ‘threshold’ for intake or a biomarker, above
which the risk of adverse effects may increase and the
dose–response relationship (Renwick et al. 2004). The
tolerable upper intake level (UL) is the highest daily
intake still considered to be safe for almost all healthy
individuals in a specified group. Depending on the
magnitude of the evidence, the UL is obtained by
downward adjustment of the no-observed-adverse-effect
level (if known) or the lowest-observed-adverse-effect
level by applying an uncertainty factor. This has
resulted for a number of micronutrients in an UL that
is close to the recommended nutrient intake because
of large uncertainty factors used to set this UL (European
Commission 2006). For some micronutrients, no evi-
dence of risk of adverse effects is established, and
hence no safe tolerable upper intake level (UL) is
defined (i.e. biotin, pantothenic acid, chromium,
vitamin B1, B2, B12 and K). For other micronutrients,
the risk of exceeding the UL is low (i.e. vitamin B6, C,
D and E, niacin, molybdenum, phosphorus and sele-
nium). For some micronutrients, a potential risk of
exceeding the maximum safe UL exists (i.e. vitamin
A as preformed retinol, zinc, iron, iodine, copper
and calcium). For the latter micronutrients, programs
should be cautiously designed and monitored to
ensure ‘at risk’ population groups are reached without
any appreciable risk of adverse effects in subgroups
that consume high amounts of the micronutrient.
Important elements of the program cycle include the
gathering of information to assess the nutrition situa-
tion, development of a national policy and strategy,
program design, implementation and monitoring,
review and evaluation, and adjustment if necessary.
Before implementing a micronutrient program it is
critical to assess the nutrition situation by collecting
data among the different population groups that can
be referred to as the ‘ABCD’ of nutrition assessment;
anthropometric assessments, biomarker or biochemical
assessments, clinical assessments (morbidity and mor-
tality) and dietary assessment. These data allow under-
standing the magnitude of the health problem and the
vulnerable population group(s) at risk of micronutrient
deficiency. Information on food and micronutrient in-
take distribution in the different population groups will
help predict how micronutrient interventions will work
in a variety of contexts. Another critical element in
planning (cost) effective and safe programs is the ongo-
ing monitoring and evaluation of the nutrition situation
through collection of data. It provides an indication of
the effectiveness and safety of the intervention and
allows adjusting the type of intervention, amount of
provided micronutrients or geographic distribution, if
needed. Some countries have implemented one or
multiple programs, focusing mostly on vitamin A,
iodine and iron. However, availability of data on
biomarkers predictive of nutrient intake, status and
adverse health effects (Combs et al. 2013; Raiten &
Combs 2015) is still sparse, and few countries have con-
ducted detailed nutrition surveys, as their collection can
be time and resource-intensive. Often multiple pro-
grams with micronutrients are implemented to reach a
greater proportion of the at-risk population. In particu-
lar, implementation of multiple micronutrient interven-
tions requires coordination and monitoring to ensure
that these programs are complementary and not over-
lapping, which may result in unnecessarily exposure of
vulnerable groups. Collecting dietary intake data and
biomarkers can be used to correct program designs to
ensure that intake ranges in the different life-stage
groups are effective and safe. Dietary intake data can
be used in software modelling to predict the shift in
micronutrient adequacy in different population groups
for a selected food vehicle and fortification level.
The need for data modelling to predict efficacy and
safety in micronutrient programs
Until recently, dietary intake modelling tools were not
able to predict the effect of intake from combined
942 M.J. Bruins et al.
© 2016 The Authors. Maternal & Child Nutrition published by John Wiley & Sons Ltd. Maternal & Child Nutrition (2016), 12, pp. 940–948
fortification and supplementation programs. As ad-
dressed in this symposium report, a new simulation ap-
proach allows to predict the effect of implementing
fortification combinedwith supplementation on intakes
below theEAR and above theUL and related program
cost versus the savings (Engle-Stone et al. 2015). Other
software tools have been developed that simulate the
effect of changing food or nutrient intakes on preven-
tion of the related burden of disease (i.e. the benefits).
In risk–benefit approaches, the same principle is used
to assess both the preventable burden of disease and
the risks related to ‘excessive’ food or nutrient intake,
provided that sufficient evidence is available to simu-
late the adverse health response. In order to use a
risk–benefit approach, a better understanding is
needed of the relation between micronutrient intake,
status and morbidity/mortality outcomes. For some
micronutrients the link between micronutrient intake,
status and morbidity/mortality is sufficiently established
to predict health benefits when overcoming its defi-
ciency (Horton 2006). However, with the current
dearth of data in many countries on micronutrient in-
take, status and related disease incidence, program
modelling to predict the benefits, and even more so
the risks, is still a challenge. It is nevertheless encour-
aging that in many countries the collection of nutrition
data is increasing, which will further help program
planners and policy-makers to design cost-effective
and safe micronutrient interventions.
Inter-individual variations and micronutrient
interactions
Minimum and maximum intake values for micro-
nutrients are relevant for population groups, but do
not necessarily reflect adequate or safe intake values
for all individuals in that group. The requirement and
safety limit for a micronutrient not only varies by age,
gender and life-stage, but also by health condition,
medication use and genetic profile, making it even
more challenging to develop a safe and effective pro-
gram tailored to all ‘at risk’ individuals. For instance,
chronic disease conditions or genetic polymorphisms
may lead to higher micronutrient requirements.
Micronutrients do not necessarily provide benefits in
all deficiency conditions; complex interactions may
exist between the deliveredmicronutrients, micronutri-
ent status, infections and medication use. Complicating
factors include (1) interactions betweenmicronutrients,
for instance iron and zinc reducing each other’s absorp-
tion (Lönnerdal 2004), (2) micronutrient–drug interac-
tions; micronutrients reducing the absorption or
efficacy of a drug or vice versa (Scaglione & Panzavolta
2014; Hathcock 1985), or (3) antagonistic interactions
between micronutrients and infections (e.g. iron and
malaria). The benefits and risks of somemicronutrients
therefore depend on the setting in which they are pro-
vided. For instance, the effect of certain micronutrients
may not only depend on whether the target population
is deficient or not, but also on whether malaria control
strategies are implemented in malaria endemic regions.
This is exemplified by the Pemba study, in which chil-
dren living on malaria-endemic Pemba island who re-
ceived iron and folic acid supplements, were more
likely to die or need treatment in hospital for an
adverse event (Sazawal et al. 2006). However, in a
sub-study of the trial in which children were given
malaria-reduction measures, children who were iron
deficient and anaemic at baseline, showed a significant
reduction in adverse events, including malaria epi-
sodes, suggesting that supplementation with iron and
folic acid may especially confer benefits to those who
are deficient.
These issues, altogether, pose a challenge to program
planners in designing micronutrient intervention pro-
grams that meet the requirements of the majority of
the population at risk while still being safe. There is a
need for tools that assist is designing micronutrient
intervention programs that are effective in reaching
the target groups at risk of developing micronutrient
deficiencies, efficient, in terms of reaching the target
group and not unnecessarily exposing non-target
groups, and safe, in terms of not overexposing a seg-
ment of the population that is already more than ade-
quate, especially vulnerable target groups. There is a
need to understand how specific micronutrients, mainly
as folic acid and iron, may interact with medication and
infection, and how they exert beneficial or antagonistic
effects under these conditions. This raises the question
of how to achieve the maximum possible public health
benefits of a micronutrient intervention strategy with
the least risks.
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Objective
During the Global Summit on Food Fortification on
9–11 September 2015 in Arusha, one of the sessions
included a special session co-organized by Sight and
Life and UNICEF, entitled ‘Effective and Safe Micro-
nutrient Interventions: Weighing the Risks against the
Benefits’. The aim of the sessionwas to identify existing
tools and needs to assist policy makers in designing
effective micronutrient programs with the highest
public health benefits and least risks. The presentations
in the session addressed this challenge, based on a
number of case studies related to folic acid, iodine
and vitamin A.
Session summary
An introduction to the session was given byDr.Maaike
Bruins (DSM Biotechnology Center, Delft, the
Netherlands), with the title ‘Assessing the risks and
benefits of micronutrients interventions’. In order to
understand the risks of inadequate and excessive intake
of a micronutrient, information is required on the in-
take distribution of themicronutrient in the population.
This enables to assess the proportion of a population
life-stage group with intakes below their requirements
and above their UL. Software is available, such as
PC-SIDE and IMAPP, for the estimation and model-
ling of food and micronutrient intake distributions,
which can assist in selecting optimal food vehicles and
fortification levels (Iowa State University 2015). Other
tools make it possible to estimate the preventable pub-
lic disease burden because of a micronutrient interven-
tion program, expressed for instance as preventable
disability-adjusted life years (DALYs). The DALY is
a quantitative measure of overall disease burden and
can serve as important guide to decision-making. The
DALYis expressed as the number of years lost because
of early death or morbidity (e.g. infections, anaemia,
motor and cognitive impairments, or blindness). The
DALY metric is composed of mortality and incidence,
duration and disability of the morbidity (related to
micronutrient deficiency). For instance, preventing
DALYs by overcoming maternal folate deficiency
may have a large public health impact; the preventable
lifelong and severe disabilities resulting from of neural
tube defects are substantial, even if a few neural tube
defects in 1000 births could be prevented. The World
Health Organization (WHO) has developed a source
of estimates for cost-effectiveness of micronutrient
interventions is the CHOosing Interventions that are
Cost Effective (WHO-CHOICE) database (World
Health Organization (WHO) 2016). The estimates
are based on known intervention costs and effective-
ness (in terms of micronutrient status), and links be-
tween micronutrient status and morbidity/mortality
outcomes. The WHO has also developed tools that
can assist program planners in simulating the public
health impact of an increase in micronutrient intake
in terms of DALYs gained (World Health Organiza-
tion (WHO) 2015). This requires (1) dietary intake
data in different population groups and (2) evidence
for a dose–response relationship between micronutri-
ent intake and morbidity because of deficiency. With
the introduction of a micronutrient intervention, the
benefits of increasing micronutrients do not always
clearly outweigh the risks. For instance, when
implementing mandatory fortification, the benefits
of preventing frequent, or severe, or life-long disabil-
ities should be balanced against the possible risks of
excess intake in other population groups (Hoekstra
et al. 2008). Risk–benefit assessment software pro-
vides the option to quantify the public health risks
and benefits, and balance them, using for instance
DALYs as a common metric (Ellis & Aspurger
2000). Even though simulating changes in DALYs
resulting from micronutrient intervention programs
can provide useful information to policy makers
to set investment priorities, the required dietary in-
take data are often lacking. Moreover, for many
micronutrients the dose–response relationship between
excessive intake and risks is not well known. Even
though simulating changes in DALYs resulting from
micronutrient intervention programs can provide
useful information to policy makers to set investment
priorities, the required intake data are often lacking
and the methods require in-depth expertise. Next to
these sophisticated modelling tools, more user-
friendly tools are needed that integrate information
on program coverage, dietary intake distribution,
biomarkers and morbidity to design effective and
944 M.J. Bruins et al.
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safe micronutrient programs in terms of public
health impact.
Increasing micronutrient intake may confer benefits
on those who have inadequate intakes. However,
micronutrient interventions may not confer benefits in
all settings. For instance, in some studies iron supple-
mentation has been associated with an increased
risk of malaria and death in children living in
malaria-endemic regions, but not when regular malaria
surveillance and treatment services are provided
(World Health Organization (WHO) 2015). Another
example of a micronutrient that may not necessarily
confer benefits under all circumstances is, for instance,
folic acid. Folic acid supplementationmay be beneficial
to the folate-deficient child, but may confer risks
when high-dose supplements are implemented in
malaria-endemic settings alongside antimalarial drugs
(Kupka 2015). This was discussed byDr.RolandKupka
from UNICEF (New York). The WHO calls for micro-
nutrient powder (MNP) programs to be implemented
alongside malaria control strategies in malaria endemic
regions. Current MNP formulations generally provide
folic acid and other micronutrients at the Recom-
mended Nutrient Intake level. However, the benefits
and risks of providing supplemental folic acid are
largely unknown. The limited data available suggest
that folate deficiency may not be a major public health
problem among children living in sub-Saharan Africa;
as a result, supplemental folic acid may not confer
health benefits. Furthermore, folic acid provided at
supraphysiological, and possibly even physiological,
levels may favour the growth of the parasite
Plasmodium falciparum (responsible for 85% of
malaria cases), inhibit clearance of the parasite by
sulphadoxine-pyrimethamine (SP)-treated malaria
and increase subsequent recrudescence (Nzila et al.
2014). Limiting prophylactic SP use or promoting the
use of insecticide-treated bed nets may render the use
of folic acid in MNP programs safer, but programmatic
barriers to these approaches may remain. The use of
5-methyltetrahydrofolic acid concomitantly with SP
may be a promising alternative, as it does not affect
SP efficacy, although its stability in food and cost-in-use
remain to be confirmed (Scaglione & Panzavolta
2014). The presentation concluded that more work is
needed to characterize the prevalence of folate
deficiency among young children worldwide, and to
optimize the benefit–risk ratio of MNP programs in
sub-Saharan Africa.
Both iodine deficiency and iodine excess have
adverse health effects. Prof.Michael Zimmerman from
the ETH Zürich (Switzerland) discussed the risks and
benefits of salt iodization programs. In general, the
relatively small risks of iodine excess are far
outweighed by the substantial risks of iodine deficiency
(Zimmermann 2008). Iodine deficiency has multiple
adverse effects on growth and development because
of inadequate thyroid hormone production, which are
termed the iodine deficiency disorders (IDD). IDD
remains one of themost common causes of preventable
mental impairment worldwide. In nearly all iodine-
deficient countries, the best strategy to control IDD
is salt iodization, one of the most cost-effective ways
of contributing to economic and social development
(Zimmermann 2008). In areas of severe iodine defi-
ciency, iodine repletion in pregnant women improves
pregnancy outcomes, eliminates endemic cretinism
and improves IQ in their children. Iodine repletion
in newborns reduces infant mortality, and may im-
prove cognitive development and growth. Even in
areas of mild-to-moderate iodine deficiency, repletion
in school-aged children improves cognition and fine
motor skills (Zimmermann 2007). On the other hand,
the introduction of iodized salt to regions with chronic
IDD may transiently increase the incidence of thyroid
disorders, such as iodine-induced hyperthyroidism
and autoimmune hypothyroidism, and programs
should therefore include monitoring for both iodine
deficiency and excess. More data on the epidemiology
of thyroid disorders caused by differences in iodine
intake are needed, and should be the focus of future
research.
The adverse effects of vitamin A deficiency include
childhood blindness, and the increased risk of mortal-
ity from measles and diarrhoea (Stevens et al. 2015).
Vitamin A supplementation and fortification programs
can be a cheap and effective way to reduce morbidity
and mortality because of vitamin A deficiency
(Horton 2006). These programs have significantly
improved millions of lives among pre-school children
in many parts of the world (Stevens et al. 2015).
Long-term excessive vitamin A intakes, on the other
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hand, can lead to adverse effects, such as hepatotox-
icity. Generally, the substantial risks of vitamin A
deficiency can be expected to far outweigh the rela-
tively small risks of vitamin A excess (Allen &
Haskell 2002). The lack of coordination of multiple
vitamin A interventions and many overlapping
schemes in some areas has increased concern about
the risks of these programs, as some children could
theoretically receive well above their recommended
daily dose of the vitamin. The uncertainty around
the level of excess for vitamin A has resulted in a
small margin of safe intake for young children, between
the recommended intake levels and maximum safe UL
‘thresholds’ (Allen & Haskell 2002). Dr. Georg Lietz
from Newcastle University (Newcastle upon Tyne, UK)
discussed how to best assess the window of benefit
for vitamin A intake. In his presentation, Dr. Lietz
highlighted the need for reliable, robust and afford-
able biomarkers of inadequate and excess status, to
enable policy and program makers to adjust the
correct level and coverage of their interventions.
The appropriate no-observed-adverse-effect level or
the lowest-observed-adverse-effect level for children
up to 5 years of age needs to be urgently determined
and the ULs revised as most ULs for children are
extrapolated from ULs for adults. Dr. Lietz also
discussed the benefits and problems associated with
the most recent methods to have been developed
to enable the monitoring of both fortification and
supplementation programs, including the application
of stable isotope dilution techniques, and the poten-
tial for lab-on-chip technologies for future monitor-
ing. He ended his presentation by highlighting the
need to coordinate different methods of risk assess-
ment, to make the monitoring process more efficient,
reliable and cost-effective.
Dr. Reina Engle-Stone from the University of
California (Davis, CA, USA) presented a dietary
modelling approach to assess the risk of inadequate
and excessive intakes under different program sce-
narios, and their applications to program planning.
Her presentation provided an overview of the meth-
odology for the use of dietary data to examine the
risk of inadequate and excessive micronutrient
intakes using dietary reference values, and given
information on current dietary patterns and the
reach of program delivery platforms. Examples from
Cameroon illustrated the use of dietary modelling to
set fortification levels, by predicting the effects of
each new or modified program on dietary intake
(Engle-Stone et al. 2015; Brown et al. 2015; Kagin
et al. 2015; Vosti et al. 2015). This dietary modelling
tool can be used to predict the effect of fortification
of different food vehicles and overlapping micronu-
trient programs on the percentage of the population
with intakes below EAR or above the UL (Brown
et al. 2015; Vosti et al. 2015). Finally, the role of com-
plementary modelling tools was discussed, including
the (1) Lives Saved Tool (LiST), which predicts the
mortality reduction from some micronutrient inter-
ventions delivered to mothers and children (Johns
Hopkins School of Public Health 2015), (2) models
assessing liver vitamin A concentration, which can
assist in the interpretation of risk of dietary intakes
above the upper intake level in young children, and
(3) program coverage surveys which reveal absent
or redundant program coverage and thus help iden-
tify subpopulations (e.g. regions) at risk of inadequate
or excessive intake (Aaron 2014; Spohrer 2015).
Population dietary intake data can be used to model
the effect of different food vehicles and micronutrient
levels to optimize coverage andminimize the risks of in-
adequate and excessive intakes in relation to dietary
cut-off points.Monitoring intake data will enable policy
makers to adjust to the correct food vehicle, micronutri-
ent level, and coverage of intervention programs. How-
ever, the success of these programs has, inevitably, to be
confirmed by applying biomarkers indicative of micro-
nutrient status that are affordable, sensitive and spe-
cific, and can be applied in population settings
(Combs et al. 2013; Raiten & Combs 2015). Some
methods which are currently applied are inadequate,
because of their lack of precision and accuracy, to de-
tect nutrient concentrations in at-risk population
groups, or because of insensitivity to changes in status
within a certain range (e.g. serum retinol), or alter-
ations during inflammation (zinc, retinol, ferritin).
Thus, improved biomarkers are urgently needed which
will enable policy makers to understand the benefits
and risks in vulnerable population groups related to
increasing micronutrient intakes. Tools are available
which assess or predict the effects of micronutrient
946 M.J. Bruins et al.
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programs, in terms of dietary intakes against dietary
cut-off points. However, there is still need for standard-
ized, user-friendly tools, which predict the public health
impact made by micronutrient interventions, by inte-
grating benefits and possible risk.More research is war-
ranted in order to understand the concerns regarding
the safety of iron and folic acid supplementation among
young children in malaria endemic areas, and their in-
teraction with antimalarials and infections. Research
is needed to assess the minimum and maximum intake
range for vitamin A outside which intakes might cause
concern. In general, the small risks of micronutrient ex-
cess are far outweighed by the substantial benefits of
overcoming the deficiency. However, there is an urgent
need tomonitor overlappingmicronutrient supplemen-
tation and fortification programs, and to evaluate the
benefits and risks (if any) of increasing population mi-
cronutrient intakes for each setting (population group,
region, choice of food vehicle, micronutrient level in
food, micronutrient status of the population group, con-
comitant food and medications, etc.).
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